MBX Biosciences, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $222 | $0 |
Gross Profit | -100 | -77 | 111 | -100 |
EBITDA | -21,805 | -26,529 | -20,330 | -19,537 |
EBIT | -26,606 | -20,388 | -19,612 | |
Net Income | -19,411 | -23,880 | -15,586 | -18,142 |
Net Change In Cash | 0 | 0 | 222 | 0 |
Free Cash Flow | -18,141 | -22,708 | -16,129 | -14,721 |
Cash | 39,781 | 29,903 | 49,351 | 132,865 |
Basic Shares | 33,446 | 33,412 | 33,392 | 33,392 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -244 | -157 | -56 |
EBITDA | -67,950 | -35,154 | -25,705 |
EBIT | -68,194 | -35,311 | -25,761 |
Net Income | -61,922 | -32,563 | -26,135 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -55,555 | -32,107 | -23,563 |
Cash | 49,351 | 30,523 | 24,210 |
Basic Shares | 33,392 | 31,853 | 31,853 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.58 |
2025-03-31 | -$0.71 |
2024-12-31 | -$0.47 |
